Literature DB >> 17928089

Influence of particle size and antacid on release and stability of plasmid DNA from uniform PLGA microspheres.

Neelesh K Varde1, Daniel W Pack.   

Abstract

PLGA microspheres are attractive DNA delivery vehicles due to their controlled release capabilities. One major problem with PLGA microspheres is that they develop an acidic microclimate as the polymer degrades, lowering the intraparticle pH, and potentially damaging the DNA. Antacids have recently shown promise in buffering this acidic microclimate and enhancing protein stability. We manufactured uniform plasmid DNA-encapsulating PLGA microspheres of two sizes (47, 80 microm diameter) and antacid concentrations (0, 3% Mg(OH)2). Microspheres with antacid had a homogeneous surface coverage of small pores, which resulted in a significant reduction of the burst effect. The 47 microm microspheres exhibited complete release of plasmid DNA over the course of two months. Incomplete release was observed from 80 microm spheres, though microspheres with 3% Mg(OH)2 showed a higher cumulative release, suggesting that the antacid at least partially aids in increasing the stability of DNA. SEM was used to visualize the surface pore evolution and cross-sectional microsphere structure over time. Subsequent image analysis was used to quantify the increase of surface pore sizes. Cross-sectional images showed increasing internal degradation and erosion, which resulted in a hollowing-out of microspheres. Our studies show that the incorporation of antacid into the microsphere structure has potential in addressing some of the major problems associated with DNA encapsulation and release in PLGA microspheres.

Mesh:

Substances:

Year:  2007        PMID: 17928089      PMCID: PMC2141539          DOI: 10.1016/j.jconrel.2007.09.005

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  29 in total

1.  Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions.

Authors:  C Berkland; K Kim; D W Pack
Journal:  J Control Release       Date:  2001-05-18       Impact factor: 9.776

2.  Pulmonary delivery of chitosan-DNA nanoparticles enhances the immunogenicity of a DNA vaccine encoding HLA-A*0201-restricted T-cell epitopes of Mycobacterium tuberculosis.

Authors:  Maytal Bivas-Benita; Krista E van Meijgaarden; Kees L M C Franken; Hans E Junginger; Gerrit Borchard; Tom H M Ottenhoff; Annemieke Geluk
Journal:  Vaccine       Date:  2004-04-16       Impact factor: 3.641

3.  How porosity and size affect the drug release mechanisms from PLGA-based microparticles.

Authors:  D Klose; F Siepmann; K Elkharraz; S Krenzlin; J Siepmann
Journal:  Int J Pharm       Date:  2006-02-28       Impact factor: 5.875

4.  Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.

Authors:  K S Jaganathan; Y U B Rao; Paramjit Singh; D Prabakaran; Swati Gupta; Anubhav Jain; Suresh P Vyas
Journal:  Int J Pharm       Date:  2005-04-27       Impact factor: 5.875

Review 5.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

6.  Stabilization of proteins encapsulated in cylindrical poly(lactide-co-glycolide) implants: mechanism of stabilization by basic additives.

Authors:  G Zhu; S P Schwendeman
Journal:  Pharm Res       Date:  2000-03       Impact factor: 4.200

7.  Controlled DNA delivery systems.

Authors:  D Luo; K Woodrow-Mumford; N Belcheva; W M Saltzman
Journal:  Pharm Res       Date:  1999-08       Impact factor: 4.200

8.  PLG microsphere size controls drug release rate through several competing factors.

Authors:  Cory Berkland; Kyekyoon Kim; Daniel W Pack
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

9.  Visual evidence of acidic environment within degrading poly(lactic-co-glycolic acid) (PLGA) microspheres.

Authors:  K Fu; D W Pack; A M Klibanov; R Langer
Journal:  Pharm Res       Date:  2000-01       Impact factor: 4.200

10.  Critical effect of freezing/freeze-drying on sustained release of FITC-dextran encapsulated within PLGA microspheres.

Authors:  Tae Hyoung Kim; Tae Gwan Park
Journal:  Int J Pharm       Date:  2004-03-01       Impact factor: 5.875

View more
  6 in total

1.  Precise control of PLG microsphere size provides enhanced control of drug release rate.

Authors:  Cory Berkland; Martin King; Amanda Cox; Kyekyoon Kim; Daniel W Pack
Journal:  J Control Release       Date:  2002-07-18       Impact factor: 9.776

Review 2.  Review physical and chemical aspects of stabilization of compounds in silk.

Authors:  Eleanor M Pritchard; Patrick B Dennis; Fiorenzo Omenetto; Rajesh R Naik; David L Kaplan
Journal:  Biopolymers       Date:  2012-01-23       Impact factor: 2.505

3.  Polymer-Based Therapeutics.

Authors:  Shuang Liu; Ronak Maheshwari; Kristi L Kiick
Journal:  Macromolecules       Date:  2009-01-13       Impact factor: 5.985

Review 4.  Application of biomaterials to advance induced pluripotent stem cell research and therapy.

Authors:  Zhixiang Tong; Aniruddh Solanki; Allison Hamilos; Oren Levy; Kendall Wen; Xiaolei Yin; Jeffrey M Karp
Journal:  EMBO J       Date:  2015-03-12       Impact factor: 11.598

5.  Computer modeling assisted design of monodisperse PLGA microspheres with controlled porosity affords zero order release of an encapsulated macromolecule for 3 months.

Authors:  Filis Kazazi-Hyseni; Mariana Landin; Audrey Lathuile; Gert J Veldhuis; Sima Rahimian; Wim E Hennink; Robbert Jan Kok; Cornelus F van Nostrum
Journal:  Pharm Res       Date:  2014-05-14       Impact factor: 4.200

6.  PLGA Nanoparticles for Ultrasound-Mediated Gene Delivery to Solid Tumors.

Authors:  Marxa Figueiredo; Rinat Esenaliev
Journal:  J Drug Deliv       Date:  2012-02-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.